According to GlobalData’s medical device pipeline database, 14 Inferior Vena Cava Filters (IVCF) devices are in various stages of development globally. GlobalData’s report Inferior Vena Cava Filters (IVCF) provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, seven are in active development, while the remaining seven are in an inactive stage of development. There are three products in the early stages of development, and the remaining four are in the late stages of development.
Cardiovascular Devices are used to detect and treat heart and circulatory system related diseases. The Inferior Vena Cava Filter (IVCF) is a metallic device used to prevent blood clots from traveling to lungs. It is placed in the inferior vena cava (IVC) through a small incision in the groin. It catches blood clots and prevent them from traveling to the lungs. It includes Retrievable IVCF, Permanent IVCF and IVCF Retrieval Devices. The filter is inserted inside a large vein called the inferior vena cava (which carries blood from lower extremities to the heart). IVC filter traps blood clots before it reaches to the lungs. It is commonly used as a preventive measure in cases where DVT and PE has been diagnosed or as a prophylactic device in cases where the risk of developing VTE is high and there is a contraindication for anticoagulants. Usage of IVC filters can prevent PE, but it does not restrict blood clot formation. IVC filters are made of non-ferromagnetic materials [Cobalt Chromium Alloy, Stainless Steel, Titanium, Nickel-Titanium (Nitinol)]. Permanent, Retrievable IVC filters and IVCF Retrieval Devices have been tracked under this segment. Permanent inferior vena cava filters (IVCF) once inserted cannot be removed or repositioned. Retrievable inferior vena cava filters (IVCF) once inserted can be retrieved or repositioned up to a certain point of time. Optional Retrievable inferior vena cava filters are used to prevent pulmonary embolism when anticoagulation is ineffective. Temporary Retrievable inferior vena cava filters are used to prevent the risk of PE for a short duration and should be ideally retrieved within 30 to 60 days. IVCF Retrieval Devices are used for removal of Retrievable IVC Filters from the vena cava.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Inferior Vena Cava Filters (IVCF) pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Inferior Vena Cava Filters (IVCF) devices. Overall, most of these Inferior Vena Cava Filters (IVCF) pipeline devices are being developed by private entities.
Key players involved in the active development of Inferior Vena Cava Filters (IVCF) include Adient Medical, APT Medical, Contego Medical, CyndRX, Interventional & Surgical Innovations, Kaleidoscope, Kaleidoscope, Koninklijke Philips, Shenzhen Salubris Pharmaceuticals and Suzhou Tianhong Shengjie Medical.
For a complete picture of the developmental pipeline for Inferior Vena Cava Filters (IVCF) devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
